Showing results (241-250 of 298) with videos related to

Sort By:
Pageof 30
The American Journal of Cardiology|December 30, 1999
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary ArteriesE M Ohman, P W Armstrong, H D White, et al.
JAMA|March 13, 1996
Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigatorsW D Weaver, H D White, R G Wilcox, et al.
The Journal of Pain|February 10, 2022
Trends in Prescriptions for Non-opioid Pain Medications Among U.S. Adults With Moderate or Severe Pain, 2014-2018Lauren R Gorfinkel, Deborah Hasin, Andrew J Saxon, et al.
Elife|March 2, 2023
O-GlcNAc glycosylation orchestrates fate decision and niche function of bone marrow stromal progenitorsZengdi Zhang, Zan Huang, Mohamed Awad, et al.
Circulation|March 14, 1998
Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-IK W Mahaffey, C B Granger, M A Sloan, et al.
The American Journal of Cardiology|April 13, 2000
Relation between evolutionary ST segment and T-wave direction and electrocardiographic prediction of mycardial infarct size and left ventricular function among patients with anterior wall Q-wave acute myocardial infarction who received reperfusion therapyY Adler, N Zafrir, T Ben-Gal, et al.
Catheterization and Cardiovascular Diagnosis|January 1, 1982
Interobserver variability in interpreting contrast left ventriculograms (CASS)L F Wexler, J Lesperance, T J Ryan, et al.
American Heart Journal|September 1, 1999
Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary ArteriesK W Mahaffey, C B Granger, M A Sloan, et al.
European Heart Journal|April 2, 2002
Clinical characteristics and outcome of patients with early (4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarctionF Zijlstra, A Patel, M Jones, et al.
American Heart Journal|September 29, 1999
Efegatran sulfate as an adjunct to streptokinase versus heparin as an adjunct to tissue plasminogen activator in patients with acute myocardial infarction. ESCALAT InvestigatorsA Y Fung, G Lorch, P A Cambier, et al.
Pageof 30